Persons
Webseiten-Inhalte
Researcher of the MedUni Vienna
...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing...
https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/detail/?name=Kilian%20_Kluge&res_id=979&cHash=1833f75425c7bf7b11515f58d3867bbf
Detailsite | MedUni Vienna
... großzelligen Lymphomen (ALCL). Dies haben Heidelberger und Wiener Wissenschafter um den Pathologen Lukas Kenner (MedUni Wien, Ludwig Boltzmann Institut für Krebsforschung und VetMedUniWien) herausgefunden und vor kurzem im renommierten "Journal of Pathology" publiziert."ALCL ist ein seltenes, aggressives Non-Hodgkin-Lymphom, das oft bei jungen Patienten vorkommt", sagte Kenner vom Klinischen Institut für Pathologie im Wiener AKH. Lymphome sind eine Art von Blutkrebs, wobei es aber zur Entstehung von Tumoren kommt. Etwa bei der Hälfte der ALCL-Patienten liegt eine Genveränderung vor, die zum Entstehen eines...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=2885&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=35b34b57009a1c59708fafb9c319691c
Detailsite | MedUni Vienna
... großzelligen Lymphomen (ALCL). Dies haben Heidelberger und Wiener Wissenschafter um den Pathologen Lukas Kenner (MedUni Wien, Ludwig Boltzmann Institut für Krebsforschung und VetMedUniWien) herausgefunden und vor kurzem im renommierten "Journal of Pathology" publiziert."ALCL ist ein seltenes, aggressives Non-Hodgkin-Lymphom, das oft bei jungen Patienten vorkommt", sagte Kenner vom Klinischen Institut für Pathologie im Wiener AKH. Lymphome sind eine Art von Blutkrebs, wobei es aber zur Entstehung von Tumoren kommt. Etwa bei der Hälfte der ALCL-Patienten liegt eine Genveränderung vor, die zum Entstehen eines...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/in-german-kleine-rna-schnipsel-foerdern-spezielle-lymphomerkrankungen/?L=3
Detailsite | MedUni Vienna
... großzelligen Lymphomen (ALCL). Dies haben Heidelberger und Wiener Wissenschafter um den Pathologen Lukas Kenner (MedUni Wien, Ludwig Boltzmann Institut für Krebsforschung und VetMedUniWien) herausgefunden und vor kurzem im renommierten "Journal of Pathology" publiziert."ALCL ist ein seltenes, aggressives Non-Hodgkin-Lymphom, das oft bei jungen Patienten vorkommt", sagte Kenner vom Klinischen Institut für Pathologie im Wiener AKH. Lymphome sind eine Art von Blutkrebs, wobei es aber zur Entstehung von Tumoren kommt. Etwa bei der Hälfte der ALCL-Patienten liegt eine Genveränderung vor, die zum Entstehen eines...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?cHash=35b34b57009a1c59708fafb9c319691c&tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=2885
Researcher of the MedUni Vienna
...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing...
https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/?cookies=CookieNotice%3D1%3Bcookie_matomo%3D1%3B&res=kilian__kluge&cHash=edf6a9526deb8fb69888a893ef79f828
Researcher of the MedUni Vienna
...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing...
https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/?res=kilian__kluge&cHash=edf6a9526deb8fb69888a893ef79f828
Researcher of the MedUni Vienna
...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing...
https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/?res=kilian__kluge&cHash=0016747d495c91eb72d200e08efcc3f5
Researcher of the MedUni Vienna
...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing...
https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/?res=kilian__kluge&cHash=c2bde58355e86017ab91c890e829af2f
Researcher of the MedUni Vienna
...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing...
https://www.meduniwien.ac.at/web/en/research/researcher-profiles/researcher-profiles/index.php?id=688&res=kilian__kluge
Researcher of the MedUni Vienna
...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing...
https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/index.php?id=688&res=kilian__kluge